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ABSTRACT
Methylation of guanosine on position N7 (m7G) on in-
ternal RNA positions has been found in all domains
of life and have been implicated in human disease.
Here, we present m7G Mutational Profiling sequenc-
ing (m7G-MaP-seq), which allows high throughput
detection of m7G modifications at nucleotide reso-
lution. In our method, m7G modified positions are
converted to abasic sites by reduction with sodium
borohydride, directly recorded as cDNA mutations
through reverse transcription and sequenced. We de-
tect positions with increased mutation rates in the
reduced and control samples taking the possibil-
ity of sequencing/alignment error into account and
use replicates to calculate statistical significance
based on log likelihood ratio tests. We show that
m7G-MaP-seq efficiently detects known m7G modifi-
cations in rRNA with mutational rates up to 25% and
we map a previously uncharacterised evolutionarily
conserved rRNA modification at position 1581 in Ara-
bidopsis thaliana SSU rRNA. Furthermore, we iden-
tify m7G modifications in budding yeast, human and
arabidopsis tRNAs and demonstrate that m7G modi-
fication occurs before tRNA splicing. We do not find
any evidence for internal m7G modifications being
present in other small RNA, such as miRNA, snoRNA
and sRNA, including human Let-7e. Likewise, high
sequencing depth m7G-MaP-seq analysis of mRNA
from E. coli or yeast cells did not identify any inter-
nal m7G modifications.
INTRODUCTION
It is becoming increasingly clear that RNA modifications
play important roles in many cellular processes and evi-
dence linking the proteins responsible for modification of
RNA to the development of human diseases is accumu-
lating (1). This is also true for methylation of guanosine
position 7 (m7G), which is present at internal positions in
both tRNA and rRNA. In the yeast small ribosomal sub-
unit (SSU) rRNA, position 1575 is m7G modified by the
Bud23-Trm112 heterodimer (2,3) and this modification is
conserved to human SSU rRNA position 1639 (4,5). Most
bacterial ribosomes are also m7G modified, including the
Escherichia coli ribosome, which has a m7G modification
both on the SSU and the LSU rRNAs (6,7). Likewise, some
tRNAs has a conserved m7G modification at position 46,
which stabilises the tertiary tRNA fold by improving the
geometry of a base triple N13-N22-m7G46 (8,9). The set of
tRNAs carrying the m7G modification is only known with
some confidence in yeast (10,11) and recently also in mice
(12) and humans (13).
The mapping of RNA modifications has been improved
by the development of a variety of sequencing based global
detectionmethods, which in some cases has allowedmRNA
modifications to be detected (14). The detection of the N1-
methyladenosine (m1A) RNA modification is an example
of this development. The m1A modification causes stops
or misincorporations during reverse transcription. Initially,
m1Awas detected on a global scale using specific antibodies
to immunoprecipitate m1A modified RNA combined with
detection of the reverse transcriptase stop events resulting
from m1A (15,16). Subsequently, the availability of ther-
mostable group II intron reverse transcriptase fusion pro-
teins (TGIRT) made it possible to increase the proportion
of m1A reverse transcriptase read-throughs compared to
stops. This allowed m1A immunoprecipitation to be com-
bined with mutational profiling of m1A, thereby increas-
ing the signal to noise ratio and improving m1A detection
(17–19). RNA modifications, including m1A, are abundant
in tRNA and their interference with reverse transcription
makes mapping of tRNA modifications challenging. Treat-
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ment with the AlkB demethylase and use of TGIRT for re-
verse transcription therefore improves tRNA profiling and
allows global detection of m1A in tRNA (20).
The m7G modification on the Hoogsteen edge does not
interfere with reverse transcription, but is specifically sensi-
tive to mild reduction with sodium borohydride (NaBH4),
which has been exploited to create abasic sites at m7G
modified RNA positions (21,22). After subsequent treat-
ment with aniline, the RNA will be cleaved at the abasic
sites, thereby allowing detection bymapping of reverse tran-
scription stops (11,21,22). This strategy forms the basis for
the tRNA reduction and cleavage sequencing (TRAC-Seq
method), which were used together with an m7G specific
antibody based method (m7G MeRIP-seq) to confidently
map the m7G modifications on mouse tRNAs (12). More
recently and while this manuscript was in review, two addi-
tional papers describing m7G mapping methods were pub-
lished (13,23). Both of the studies combined m7G MeRIP-
seq results with results from methods based on RNA re-
duction with NaBH4 and biotinylation of abasic sites with
biotin reagents. Pandolfini et al. developed a method called
Borohydride Reduction sequencing (BoRed-seq) based on
pull-down of the biotinylated RNA fragments followed by
sequencing and applied it to human miRNAs, which led to
the discovery of several human miRNAs with m7G mod-
ifications, including Let-7e, which was further character-
ized (23). Zhang et al. detected m7G modifications at nu-
cleotide resolution by mapping of mutations occurring as
a result of misincorporation at the biotinylated sites dur-
ing reverse transcription and use their methods to map 803
m7G mRNA modifications in human mRNA as well as
m7G modifications in human tRNAs (13).
Here, we describe the m7GMutational Profiling sequenc-
ing (m7G-MaP-seq)method for high throughput nucleotide
resolution mapping of internal m7G modifications. Our
method is based on NaBH4 treatment of RNA and di-
rect detection ofmutations resulting frommisincorporation
at abasic sites during reverse transcription. We show that
m7G-MaP-seq detects known and novel m7Gmodifications
in rRNA and tRNA with mutational rates of up to 25%.
We find that arabidopsis SSU rRNA has an m7G modifi-
cation at position 1581, which corresponds to the location
of the SSU rRNA position modified both in human and
yeast rRNA, suggesting that the SSU m7G modification is
universally conserved in eukaryotes. Moreover, by applying
m7G-MaP-seq to small RNA sequencing libraries, we de-
tect tRNAm7Gmodifications from yeast, human and Ara-
bidopsis. In contrast, m7G-MaP-seq analysis of other types
of short RNAs and of E. coli and yeast mRNAs failed to
identify any internally m7G modified positions.
MATERIALS AND METHODS
Cell culture and RNA isolation
Yeast MATa strain BY4741 (cat. no. YSC1048) were ob-
tained fromGEHealthcareDharmacon (DharmaconYeast
Knockout collection). The yeast cells were grown at 30◦C
in YPD medium. At OD = 0.75, the cells were collected by
centrifugation, and pellets were washed with ice-cold water
and re-suspended in 400 l ice-cold TES solution (10 mM
Tris–HCl pH 7.5, 10 mM EDTA pH 8.0, 0.5% SDS). RNA
was extracted using a hot acid phenol protocol.
The E. coli Keio Knockout RsmG strain (OEC4987-
213607518) and the parental BW25113 strain (OEC5042)
were obtained from GE Healthcare Dharmacon (E. coli
Keio Knockout panel). The strains were inoculated in
Luria-Bertani (LB)media (containing 50g/ml kanamycin
for the knockout strains). Overnight cultures were diluted
1:100 and at OD600 = 0.4, ice-cold EtOH/Phenol stop so-
lution (5% saturated phenol (pH < 7.0) 95% ethanol) was
added (6.25 l per 25 ml cell culture). Cells from 25 ml cul-
ture were pelleted at 3000 g for 5 minutes at 4◦C and resus-
pended in 800 l TE buffer (100 mM Tris, 10 mM EDTA,
pH. 8.0) with 0.5 mg/ml lysozyme, followed by the addition
of 1/10 vol of 10% Sodium dodecyl sulphate (SDS). After
incubation at 64◦C for 2 min, 1/10 vol of 1 M NaOAc, pH
5.2 was added, followed by addition of an equal volume of
water saturated phenol (pH< 7.0). After incubation at 64◦C
for 6 min and centrifugation at 14 000 g for 10 min at 4◦C,
the aqueous layer was transferred to a new tube contain-
ing an equal volume of chloroform, inverted repeatedly, and
centrifuged at 14 000 g for 5 min at 4◦C. The aqueous layer
was ethanol precipitated, and the RNA pellet was dissolved
in RNase-free water.
Arabidopsis Columbia-0 seeds were washed in 96%
ethanol followed by 10% bleach, spread onto solid agar
plates and incubated 48 h at 4◦C in darkness. Next, the seeds
were incubated under light and harvested at day 14. The
plant tissue was grinded in liquid nitrogen, and 100 mg of
the grinded tissue wasmixed with 1ml of Trizol (Invitrogen,
cat # 15596026), followed by addition of 200l chloroform.
After vortexing, samples were centrifuged at 14 000 g at 4◦C
for 10minutes and 500l of the supernatant wasmixedwith
500 l isopropanol and incubated at room temperature for
30 minutes. RNA was pelleted by centrifugation at 14 000 g
at 4◦C for 15 min and washed with twice with 70% ethanol
before resuspension in RNase-free water.
HeLa cells were cultured in DMEM medium con-
taining 10% Foetal Bovine Serum, 1% L-glutamate, 1%
penicillin/streptomycin. The cells were harvested at ∼80%
confluency and RNA was isolated using Trizol reagent (In-
vitrogen, cat. # 15596026) according to the manufacturer’s
protocol.
DNase treatment
DNA was depleted from the RNA using the RNase Free
DNase Set (Qiagen, cat. # 79254) according to manufac-
turer’s protocol. The RNA quality was assessed on an Agi-
lent 2100 Bioanalyzer using a RNA pico assay (RIN values
were >9).
mRNA enrichment
RNA from yeast were poly(A)-enriched, using the Poly(A)
Purist MAGKit (Ambion, cat. # AM1922), using the stan-
dard protocol. The enrichment procedure was performed
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twice. RNA fromE. coliwas rRNA depleted using the Ribo
Zero rRNA removal Kit (Illumina, cat. # MRZGN126).
Poly-A enriched or rRNA depleted RNA was purified with
Agencourt Ampure XP RNAclean beads (Beckman Coul-
ter, cat. # A63987) in a sample:beads ratio of 1:1.2, to re-
duce the small RNA fraction. The purification was per-
formed according to the manufacturer’s protocol and the
purified RNA was eluted in 10 l RNase-free water.
Fragmentation
The RNA was mixed with an equal volume of 2× fragmen-
tation buffer (100 mM Tris–HCl (pH 8), 10 mM MgCl2),
and the samples were incubated at 95◦C for 3 min and 20 s.
The samples were then placed on ice and EDTA was added
to a final concentration of 10 mM. The RNA was purified
with Agencourt Ampure XP RNAclean beads (Beckman
Coulter) in a sample:beads ratio of 1:3.6, and the purified
RNA was eluted in 10 l of 1 M Tris pH 8.2.
NaBH4 reduction
Fragmented RNA was either incubated with 0.3 M freshly
prepared NaBH4 (NaBH4 (+) samples) or with RNase-free
water (NaBH4 (–) samples). The pH of the 0.3 M NaBH4
solution was 9. The reactions were incubated on ice for 30
min in darkness, followed by ethanol precipitation of the
RNA, which were used directly for reverse transcription to
preserve abasic sites.
First-strand cDNA synthesis (total RNA and mRNA sam-
ples)
Reverse transcription was performed with the PrimeScript
Reverse Transcriptase (Takara Bio) in 35 l reactions us-
ing 10 l of RNA as template. 100 M reverse transcrip-
tion primer (RT random primer, see supplementary S1)
was added to RNA sample and the mixture was incubated
at 65◦C for 5 minutes and placed immediately on ice. Next
7.5 l 5× Primescript buffer, 7.5 l 3.3 M/0.6 M sorbitol–
trehalose mix, 1.9 l 10 mM dNTP, 7.6 l water and 1.5
l Primescript reverse transcriptase to each reaction and re-
verse transcription was carried out at 25◦C for 30 s, 30◦C for
10 min, 42◦C for 30 min, 50◦C for 10 min, 56◦C for 10 min,
60◦C for 10 min. The cDNA was purified with Agencourt
AmpureXP beads (BeckmanCoulter) in a sample:beads ra-
tio of 1:1.8, and eluted in 35 l water. The cDNA was then
vacuum concentrated to 7 l.
3′-end adapter ligation
Ligation of the adapter to the 3′-end of the cDNA was per-
formed using CircLigase ssDNA Ligase (Epicentre) in 10
l reactions. Initially, 3 l RNA/cDNA duplex were mixed
with 0.5 l 100 M Ligation adapter (see supplementary
S1) on ice, followed by addition of 6.5l mastermix consist-
ing of 1l CircLigase buffer, 0.5 l ATP, 0.5 l MnCl2, 2l
50% PEG 6000, 2 l betaine and 0.5 l CircLigase enzyme.
Reactions were transferred to a thermocycler and incubated
2 h at 60◦C, 1 h at 68◦C, and 10 min at 80◦C to inactivate
the enzyme. The cDNA was purified with Agencourt Am-
pure XP beads (Beckman Coulter) in a sample:beads ratio
of 1:1.8, and the purified cDNA was eluted in 10 l water.
Library amplification by PCR
The amplification of the library was conducted using
Phusion® High-Fidelity DNA Polymerase (New England
Biolabs, Cat #m0530) and custom Illumina-compatible
primers (see supplementary S1). Reactions of 50 l were
prepared and consisted of 7 l single stranded cDNA, 3 l
forward primer, 2.5 l reverse index primer, 10 l Phusion
5× HF buffer, 4 l 2.5 mM dNTPs, 22.5 l water and 1 l
Phusion Polymerase.
The reactions were denatured for 3 min at 98◦C, followed
by 4 cycles of 98◦C for 80 s, 64◦C for 15 s and 72◦C for 1
min followed by 14–17 cycles of 98◦C for 80 s and 72◦C for
1 min and subsequently 72◦C for 5 min.
The samples were pooled and run on the E-Gel® iBase™
Power System (Thermo Fisher) with the ‘SizeSelect 2%’
program to remove primer-adapter contamination. Follow-
ing collection of the 150–600 bp fraction, the pooled library
was ethanol precipitated, and sequenced on the Illumina
NextSeq platform.
Small RNA library preparation
Total RNA (1 g) with a RIN value of 9.8 or higher was ei-
ther NaBH4 or mock treated as described in the ‘NaBH4 re-
duction’ section. Small RNA libraries of yeast, human and
arabidopsis were prepared using ‘The NEBNext Multiplex
Small RNA’ kit according to manufacturer’s protocol. The
pooled libraries were run on the E-Gel® iBase™ Power Sys-
tem (Thermo Fisher) with the ‘SizeSelect 2%’ program, to
remove 5.8s rRNA and to selectively exclude the >250 bp
fraction. The pooled libraries were ethanol precipitated and
sequenced on the Illumina NextSeq platform.
SSU rRNA sub-fragment isolation and mass spectrometry
analysis
An ∼50 nucleotide fragment of the A. thaliana SSU rRNA
sequence around G1581 was isolated for MALDI Time-of-
Flight mass spectrometric analysis. Purified total RNA was
hybridized with a complementary oligodeoxynucleotide
Ara LSU 1581 (Supplementary Table S1), followed by di-
gestion with mung bean nuclease and RNase A as de-
scribed in (24). After sub-fragment purification on a de-
naturing polyacrylamide gel, the RNA was separately di-
gested with RNase A (pyrimidine-specific) for mass spec-
trometric analysis as previously reported (25). Briefly, 1–2
pmol rRNA sub-fragment were RNase A digested to com-
pletion and analysed using 3-hydroxypicolinic acid as ma-
trix. Mass spectra were recorded in positive ion mode with
a reflectron Time-of-Flight mass analyzer on a Bruker Ul-
traFlex MALDI instrument and processed using the soft-
ware ‘m/z’ (Proteometrics). The observed digestion pat-
tern was compared to a theoretical ditto calculated using
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GPMAW software (Lighthouse Data, Denmark). Tandem
mass spectrometry to investigate exact positions of the ob-
served modifications was performed on a Waters Q-TOF
Premiere instrument (Waters, Manchester, UK) equipped
with a MALDI ion source in positive ion mode as previ-
ously described (26).
Reads pre-processing and mapping
All raw data files and the fines processed datafiles contain-
ing the data used for making figures are available at GEO
under accession GSE121927. The analysis is described in
detail at https://github.com/jeppevinther/m7g map seq. In
brief, sequencing reads from regular RNA-Seq experiments
were processed with Cutadapt to remove adapter sequences
and trim dark cycle artefacts from the two colour Nextseq
platform using the options -a AGATCGGAAGAGCA-
CACGTCT –nextseq-trim = 20’. The preprocessing.sh
script from RNAProbR package (27) (http://people.binf.
ku.dk/~jvinther/data/rna probing/) was used to remove the
7 base barcode from the sequencing read using the options ‘-
b NNNNNNN -t 9’ and the barcode information was saved
in a separate file. Reads having one or more Ns in the bar-
code sequence were discarded before mapping with bowtie2
using high sensitivity options ‘–local -N 1 -D 20 -R 3 -L 15’.
For analysis of ribosomal rRNA, reads were mapped
to ribosomal sequences obtained from the CRW database
(28). For E. coli mRNA analysis, reads were mapped
to the ensembl cDNA release 87 for the bw25113 strain
ftp://ftp.ensemblgenomes.org/pub/release-29/bacteria/
/fasta/bacteria 87 collection/escherichia coli bw25113/
cdna/Escherichia coli bw25113.GCA 000750555.1.
29.cdna.all.fa.gz. For yeast mRNA analysis, reads
were mapped to the ensembl cDNA release 84 of S.
cerevisiae ftp://ftp.ensembl.org/pub/release-84/fasta/
saccharomyces cerevisiae/cdna/Saccharomyces cerevisiae.
R64-1-1.cdna.all.fa.gz. Potential PCR duplicates among
the sequencing reads were removed by discarding all,
but one of the reads having identical barcode and map-
ping to the same position using the collapse.sh script
(http://people.binf.ku.dk/jvinther/data/RNA-seq).
Sequencing reads from small RNA-Seq experiments were
processed and mapped using the settings described above
but as these reads do not include the adapter barcode, no
pre-processing and collapsing of PCR duplicates on bar-
codes were performed. For tRNA analysis of yeast, hu-
man and arabidopsis, reads were mapped to the high con-
fidence tRNA fasta sequences obtained from the genomic
tRNA database (http://gtrnadb.ucsc.edu/index.html). Prior
to mapping, redundant/identical RNA sequences from
different genes were collapsed, tRNA introns were re-
moved from the sequences and 3′ terminal CCA were
added. For histidine tRNAs a 5′ G were added to the
sequence. In the analysis of unspliced tRNA, both the
spliced and unspliced tRNA sequences were included in
the fasta sequence used for mapping. For the analysis of
Arabidopsis and human miRNAs, reads were mapped to
the miRbase miRNA precursor annotation ftp://mirbase.
org/pub/mirbase/CURRENT/hairpin.fa.gz. Sequences for
other sRNA were obtained using BioMart from the En-
sembl human gene (GRCh38.p12) annotation with a fil-
ter restricting to genes annotated as ‘scaRNA, scRNA,
snoRNA, snRNA, sRNA’ and Arabidopsis thaliana gene
(TAIR10) annotation with a filter restricting to genes an-
notated as ‘snoRNA, snRNA, SRP RNA’.
Detection of mutations and statistical analysis
The mapped reads for the control and NaBH4 treated sam-
ples were processed with the mpileup tool from the sam-
tools package using per-Base Alignment Quality, which es-
timates the probability of a read base being wrongly aligned
(29,30). To parse the mpileup output into tabular form and
perform statistical analysis, we developed an R-script (get-
Freq2000.R) based on the statistical principles developed
for the ANGSD package (31). The statistics employed in
the script is described in the Supplementary methods and
the getFreq2000.R script is available at https://github.com/
jeppevinther/m7g map seq. Briefly, the R function takes a
samtools mpileup output file as input and outputs a num-
ber of statistics for each position, including the sequencing
depth, the estimated mutation frequency for the treated and
control samples taking the probability of a read base being
wrongly aligned into account. The mutation rate difference
used for plotting in most of our figures is the estimated mu-
tation frequency for the control subtracted from estimated
mutation frequency for the treated sample. In addition, the
script uses log likelihood tests to calculate P-values for the
estimated mutation rates being different in the treated and
the control samples. Likewise, it also tests for differencemu-
tation rates within the replicate samples. For a full descrip-
tion of the output of the R script, see Supplementary Table
S2.
Data analysis
The output from the getFreq function was used for plot-
ting and further data analysis in R. For the rRNA analysis,
only positions having a sequencing depth higher than 500
was used. For the tRNA and mRNA analysis, only posi-
tions having a combined sequencing depth higher than 1500
in the six samples, an average mutation frequency less than
1% in the control replicates, and no significant difference in
mutation rates (P-value < 10−5) within control or NaBH4
treated replicates were used for preparing figures. TheMod-
omics database (10) was used for annotation of tRNAm7G,
m1A and dihydrouridine positions.
RESULTS
m7G-MaP-seq detects m7G modifications
In m7G-MaP-seq, we exploit the specific sensitivity of
m7G to mild reduction with sodium borohydride (NaBH4),
which lead to formation of RNA abasic sites (Figure 1A).
In contrast to previousmethods, we preserve the abasic sites
in the RNA and use reverse transcription with the Prime-
script MMLV reverse transcriptase to record the positions
of m7G modifications directly as mutations in the cDNA
primary sequence (Figure 1A and Supplementary Figure
S1). The cDNA is used to prepare libraries for massive par-
allel sequencing and the resulting data is mapped to a rel-
evant reference using local alignments and high sensitiv-
ity settings. To perform data analysis and detect positions
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Figure 1. (A) Schematic representation of the m7G-MaP-Seq method. NaBH4 treatment leads to formation of abasic sites at m7G positions, which subse-
quently are converted into cDNAmutations during reverse transcription and detecte by massive parallel sequencing. (B) Detection of m7G at E. coli SSU
rRNA position 527 and E. coli LSU rRNA position 2069 in WT strain. (C) Detection of m7G at E. coli SSU rRNA position 527 and E. coli LSU rRNA
position 2069 in RsmG knockout strain. (D) Boxplots showing consistent detection of m7G modified positions in biological replicates.
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with increased mutation rates in the reduced samples com-
pared to control samples, we developed a pipeline based on
the mpileup tool from the samtools package (29,30) and a
new tool called getFreq, which we developed based on the
ANGSD package (31). Our new tool takes the observed se-
quenced bases and the possibility of sequencing/alignment
error into account to calculate estimated mutation rates for
the treated and control samples, which are subtracted to
give a mutation rate difference for each position. More-
over, our tool uses replicates samples to calculate the sta-
tistical significance of the mutation rate difference based
on log likelihood ratio tests and several other statistics (See
Supplementary Table S2 and the SupplementaryMethods).
To validate the method, we first applied m7G-MaP-Seq to
E. coli rRNA, where two m7G modifications are known.
One is located in the conserved 530 loop of hairpin 18 in
the bacterial SSU rRNA (m7G527 in E. coli) (7) and the
other at position 2069 within the peptidyl transferase center
of LSU rRNA (6). NaBH4 treatment specifically induced
deletions and misincorporations at the two known m7G
modified positions and resulted in mutation rate differences
of 10% and 5% (Figure 1B), respectively. To demonstrate
that our method specifically detects the m7G modifications
and not some other feature of positions 527 and 2069, we
repeated the experiment using a knockout strain for the
RsmG methyltransferase known to carry out the modifi-
cation at position 527 (7). As expected, we found that the
knockout specifically eliminated NaBH4 treatment induced
mutations at position 527, while the normalised mutation
rate of any other position remained unaffected (Figure 1C).
Next, we applied m7G-MaP-Seq on three biological repli-
cates and found that the observed mutation rate differences
for each position were highly reproducible between the
replicates within the experiment (Figure 1D), whereas we
observe some variation in the mutation rates obtained be-
tween different experiments (compare Figure 1B with 1D).
To analyse the relationship between the modification fre-
quency and the observedmutation rates, we first established
that theE. coli SSU position 527 100%m7Gmodified in the
WT stain and absent in the RsmG knock out strain using
mass spectroscopy (Supplementary Figure S2A). We then
prepared known mixtures of RNA isolated from the WT
and RsmG strains and applied m7G-MaP-Seq to the sam-
ples. We find that there is a linear relationship between the
known m7G modification frequency in the samples and the
observed mutation rate differences, although were observed
mutation rates were somewhat lower in this particular ex-
periment (Supplementary Figure S2B). As expected for re-
verse transcription of abasic sites, we find that the m7G-
MaP-Seq signal is composed of all possible types of mu-
tations, including insertions and deletions (Supplementary
Figure S2C). Both the observed mutation rates and types
of mutations vary among different m7G positions, indicat-
ing that the flanking sequences influence the reverse tran-
scription of abasic sites. Apart from mutations, we find that
reverse transcription of the abasic sites leads to a relatively
small relative increase in the count of reverse transcription
(RT)-stops observed at the m7G modified positions (Sup-
plementary Figure S3), indicating that the Primescript re-
verse efficiency reverse transcribes abasic sites at the reac-
tion conditions used in m7G-MaP-Seq.
m7G-MaP-seq detects known and novel m7Gmodifications in
rRNA
Next, we applied m7G-MaP-seq to total RNA isolated
from yeast (S. cerevisiae), arabidopsis (A. thaliana) and hu-
man (H. sapiens) cells in a single replicate. For both hu-
man and yeast rRNA, we detect the known small subunit
(LSU) rRNA m7G modification at positions G1639 and
G1575, respectively (Figure 2). In arabidopsis SSU rRNA,
no m7G methylation equivalent to the G1575 methylation
in yeast has been described, but m7G-MaP-seq detects an
m7G modification at position G1581, which aligns to the
yeast SSU rRNA G1575 (Figure 2C). To further validate
the arabidopsis m7G methylation at SSU G1581, we puri-
fied an RNA fragment surrounding the position and sub-
jected it to RNase A digestion and Matrix-Assisted Laser
Desorption/Ionization mass spectrometry (MALDI-MS)
and tandem mass spectrometry. The mass spectrometry
analysis demonstrates two methylations in the RNase A
product G1578-U1584, m/z 2375.42––and a spontaneous
truncation of this, G1578-A1582, m/z 1722.28––close to
100%modified (Figure 2B). Tandemmass spectrometrywas
applied to pinpoint the methylation in G1578-U1584 (Sup-
plementary Figure S4) andG1578-A1582 (data not shown),
where the two methyl groups were assigned to A1579 and
G1581, respectively. The loss of a methylated G base (m/z
2210.35) shows that the methylation of position 1581 is on
the guanine. This demonstrates that the SSUG1581 methy-
lation is conserved in arabidopsis (Figure 2C).
m7G-MaP-seq maps m7G modifications in tRNA
A subset of tRNAs are m7G modified at position 46 in
the variable loop and for yeast tRNAs, the m7G modifica-
tions have been annotated (10). We applied m7G-MaP-seq
to small RNA isolated from yeast in biological triplicates
with one treated and one control library per replicate. For
tRNAs, we mapped to sequence files containing all known
tRNA isodecoders and used high sensitivity mapping set-
tings, which allows distinction of tRNA isodecoders differ-
ing in as little as one sequence position. When sequencing
reads cover both the potential m7G modification at posi-
tion 46 and the positions that differ between isodecoders,
our analysis has the potential to detect isodecoder specific
m7G modifications. The analysis was limited to tRNA po-
sitions with a sequencing depth of more than 1500 in the six
samples combined, an average mutation frequency <1% in
the control replicates, and no significant difference in muta-
tion rates within replicates (see Methods for details). Some
tRNAs, such as Ile-TAT-2, Pro-AGG-1 and Thr-TGT-2
showed highly significant mutation rate differences specif-
ically at position 46, whereas others, such as tRNA-Gly-
TCC-1 did not (Figure 3A).
To detect m7G modification on a global scale, we plot-
ted the observed difference in mutation rate versus the P-
value obtained for the comparison of the control samples
with the NaBH4 treated samples for all positions (Figure
3B). Using a cut-off of 0.5% for the mutation rate differ-
ence and P-value threshold 10−50 for the difference between
rates, we specifically predict all but three of the m7Gs anno-
tated in the Modomics database for yeast tRNAs as having
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Figure 2. (A) Detection of m7Gmodifications in yeast, human and arabidopsis SSU rRNA. (B) Detection and validation of the m7Gmodification at Ara-
bidopsis SSU rRNA position 1581 using mass spectroscopy. (C) Conservation of SSU rRNAm7Gmodification between yeast and Arabidopsis (secondary
structures from the CRW database).
m7G modifications (Figure 3B) (10). The three tRNA for
which no m7G modification is detected are Met-CAU, Lys-
UUUandCys-GCAand they all have increased relative fre-
quency and a P-value <10−10 but does not reach our strict
cut-off (Figure 3B). For two tRNAs (tRNA-Pro-AGG and
tRNA-Thr-TGT) not previously known to be m7G modi-
fied, the m7G-MaP-seq data predict that position G46 is in-
deed modified (Figure 3C, Supplementary Table S3). More-
over, the m7G-MaP-seq analysis also shows that several tR-
NAs with G in position 46 do not show any signs of modifi-
cation (Ala-AGC-1, Ala-TGC-1, Leu-GAG-1, Leu-TAA-1,
Leu-TAG-1, Ser-AGA-1 and Ser-AGA-2, Ser-GCT-1).
In addition to m7G positions, some positions known
to be N1-methyladenosine (m1A) and Dihydrouridine (D)
modified also pass our filter and have increased relative
mutation frequency and low P-values (Figure 3B). Dihy-
drouridine positions are known to be susceptible to NaBH4
reduction, potentially leading to the formation of abasic
sites (32). For known m1A positions, we consistently find
increased mutation rates in the NaBH4 treated samples,
suggesting that m1A is susceptible to mild reduction with
NaBH4 (Supplementary Figure S5).
A subset of yeast tRNAs undergoes splicing and it is not
known whether these tRNAs are m7G modified before or
after splicing takes place. We therefore compared the m7G-
MaP-Seq signal from the reads mapping to the unspliced
and the mature tRNA, respectively. As previously demon-
strated for tRNA m1A modifications, we find that the un-
spliced yeast tRNA molecules are m7G modified on posi-
tion 46 prior to splicing, suggestion that m7G modification
take place early in tRNA maturation (Supplementary Fig-
ure S6). Next, we applied m7G-MaP-Seq to small RNA iso-
lated from human HeLa cells and arabidopsis (Figure 4).
Human and arabidopsis tRNAs have more RT-terminating
modifications such as m1A, N3-methylcytidine (m3C) and
N1-methylguanosine (m1G) and N2,N2-dimethylguanosine
(m22G), resulting in relatively fewer tRNAs having suffi-
cient sequencing depth for analysis. Nevertheless, among
the tRNAs expressed in HeLa cells, m7G-MaP-seq identi-
fies eight different tRNA isodecoder families modified at
position 46 (Figure 3D), for all of which the homologous
mouse tRNAwere previously found to be m7Gmodified by
the TRAC-seq method (12). For tRNA-Val-CAC, we find
that isodecoders 1, 2 and 3 are all m7Gmodified on position
46, whereas the isodecoder 11 did not show any evidence of
modification in m7G-MaP-seq.
There is no available annotation of m7G tRNA modifi-
cations in arabidopsis and we therefore applied m7G-MaP-
seq to small RNA purified from arabidopsis 14-day old
seedlings (Figure 3E). Based on the analysis, we predict that
Arg−ACG, Asn−GTT, Asp−GTCMet−CAT, Pro−TGG,
Thr−TGT, Trp−CCA−3, Thr−GGT and Thr−TGT are
m7G modified, whereas Arg-TCT, Glu-TTC and Leu-TAG
are not modified.
No evidence for m7G modifications in human miRNAs, in-
cluding human Let-7e
Kouzarides and colleagues recently reportedm7Gmodifica-
tions within a subset of human miRNAs, including Let-7e,
for which them7Gmodification was validated and localized
to position 18 using mass spectroscopy of a RNaseA frag-
ment of the miRNA (Figure 4A) (23).While the application
of m7G-MaP-seq to human small RNAs mapped known
tRNA m7G modifications with high confidence (see Figure
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Figure 3. (A) Sequencing depth andm7G-MaP-seq -10*log 10(p-val) for selected yeast tRNA. (B)Mutation rate difference versus -10*log 10(P-val) plot of
all detected yeast tRNA positions. Known m7G positions are specifically detected by m7G-MaP-seq. (C) m7G-MaP-seq -10*log 10(p-val) for yeast tRNA
positions aligning to position 46 in the tRNA variable loop. (D) Mutation rate difference vs -10*log(p-val) plot of all detected human tRNA positions. (E)
Mutation rate difference vs -10*log 10(p-val) plot of all detected arabidopsis tRNA positions.
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Figure 4. (A) Sequences of the Human Let-7e precursor and human LSU rRNA 4333-4345. Identical RNase A fragments are indicated as well as the
Let-7e position reported by Pandorfini et al. to be m7G modified and the corresponding 2’ OMe G4340 position known to be modified in LSU rRNA
and guided by snoRNA U60 (Krogh et al.). (B) Mutation rate difference versus –10*log(P-val) plot for 1239 Gs in 175 different human miRNAs. (C)
Coverage and P-values obtained for the Human Let-7e precursor sequence. Position 18 is indicated. (D) Analysis of the power to detect m7Gmodification
at position 18 in the human Let-7e. The curves show the power for 4 different detection levels of m7G modifications with the sequencing depth observed
for Let-7e.
3), we find no evidence of m7Gmodifications in any human
miRNA (Figure 4B). For Let-7e, we have very high sequenc-
ing depth (Figure 4B) but we do not observe any mutations
in the treated samples for this position. In this specific ex-
periment, tRNAs m7G positions are detected with muta-
tional rates in the range of 0.5% to 6% (Figure 3D). If we
conservatively assume that the m7G modification on Let-
7e would also be detected with a 1% mutation rate if 100%
modified, then we estimate that we would have 100% power
to detect the Let-7e modification with a P-value better than
10−5 if 10% of Let-7e molecules were m7Gmodified (Figure
4C). The fact that we do not observe any mutations for Let-
7e position 18 demonstrates that for the HeLa cells used in
our study, this position is notm7Gmodified at a biologically
relevant level.
No evidence for m7G modifications in yeast and E. coli mR-
NAs
In human mRNAs, 803 m7G modified positions were re-
cently reported, suggesting thatmRNA in other speciesmay
also bem7Gmodified.We appliedm7G-MaP-seq tomRNA
from E. coli and yeast in biological triplicates. In our anal-
ysis, 193590 E. coli mRNA (Figure 5A) and 377837 yeast
mRNA G positions (Figure 5B) had a sequencing depth of
more than 1500 in the three control and three treated repli-
cates combined, an average mutation frequency<1% in the
control replicates, and no significant difference in mutation
rates within replicates (see Materials and Methods for de-
tails). This corresponds to approximately 20% and 16% of
the G content of the entire transcriptome of E. coli and
yeast, respectively. However, in neither of the two analy-
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Figure 5. (A) Mutation rate difference versus –10*log 10(P-val) plot for E. coli mRNA G positions (n = 193 590) and E. coli rRNA G positions. The
two known E. coli ribosomal m7G modifications are indicated. (B) Mutation rate difference versus –10*log 10(P-val) plot for yeast mRNA positions (n
= 377 837). The known yeast ribosomal m7G modification at 1575 is indicated.
ses, we find any evidence of internal mRNA positions being
m7G modified. In contrast, we find the known ribosomal
m7G modifications at E. coli SSU 527 and LSU 2069 (Fig-
ure 5A) and yeast SSU 1575 (Figure 5B) are detected with
high mutation rate differences and high confidence.
DISCUSSION
In this paper, we present m7G Mutational Profiling se-
quencing (m7G-MaP-seq), which allows sensitive and high
throughput detection of internal m7G modifications in any
type of RNA. Mutational profiling has previously been ap-
plied to obtain nucleotide resolution mapping of RNA-
protein interactions, m1Amodifications and for Selective 2-
hydroxyl acylation analysed by primer extension (SHAPE)
based probing of RNA structure, and here we demonstrate
that this strategy also can be successfully applied to detect
internal m7G modifications. Our method is based on the
treatment of RNAwithNaBH4, leading to the formation of
abasic sites at m7G positions. Abasic sites in RNA are rel-
atively stable, and during the subsequent reverse transcrip-
tion m7G positions are permanently recorded as mutations
in the cDNA sequence. m7G-MaP-seq can be implemented
in any sequencing protocol, including regular RNA-seq
experiments, and small RNA-seq by addition of NaBH4
treated samples in the experimental setup and application
of our pipeline for data analysis. Compared to methods
based on the mapping of reverse transcription stops, mu-
tational profiling makes better use of the sequencing reads
and has improved sensitivity because bias from RNA frag-
mentation, adapter ligation and secondary structures is re-
duced. In global RNA modification mapping experiments,
it becomes very important to establish the background de-
tection rates and account for these when modifications are
mapped (33). We developed a pipeline that incorporates
re-estimated base qualities, which are used to provide esti-
mated mutation frequencies using an EM-algorithm. In ad-
dition, our tool applies log likelihood ratio tests to obtain
P-values for differences in mutation rates both within repli-
cates and between the control and NaBH4 treated samples,
making m7G-MaP-seq highly suitable for global analyses.
Apart from m7G, we also find that NaBH4 treatment in-
duces increased mutation rates of N4-acetylcytidine (ac4C),
dihydrouridine (D) and m1A. This is in agreement with a
recent publication using NaBH4 treatment for detection of
ac4C (34) and the known susceptibility of D for cleavage
of the dihydrouridine ring upon reduction by NaBH4 (32).
In contrast, for m1A positions NaBH4 treatment was not
expected to lead to increased mutation rates. Rather, the al-
kaline conditions during reduction could potentially lead to
Dimroth rearrangement to m6A and thereby decrease mu-
tation rates, as previously used to improve m1A signal in
global sequencing-based mapping experiments (15). Typi-
cally, the Dimroth rearrangement is performed at elevated
temperatures (35), whereas we here perform NaBH4 treat-
ment on ice, which likely explains that we do not observe
widespread rearrangement to m6A and decreased mutation
rates. NaBH4 treatment of m1A results in the formation of
1-methyl-6-hydroadenosine, which is fairly stable, but can
be re-oxidized to m6A (35). The reduction to 1-methyl-6-
hydroadenosine results in the loss of planar conformation
and aromatic character of the six-membered ring. Our re-
sults suggest that 1-methyl-6-hydroadenosine is relatively
stable under our conditions and that A is relatively effi-
ciently incorporated into cDNA during reverse transcrip-
tion at 1-methyl-6-hydroadenosine positions (Supplemen-
tary Figure S5B).
We find that different m7G positions have variation in
their m7G-MaP-seq mutational rates, which may be the re-
sult of differences in the level of m7G modification, but
probably also reflects that the local sequence influences the
efficiency of abasic sites formation during reduction and of
reverse transcriptase abasic site read-through. In this study,
we successfully use MMLV based reverse transcriptases
Primescript (total RNA and mRNA libraries) and Proto-
script II (small RNA libraries) for m7G-MaP-seq, however,
the use of thermostable group II intron reverse transcriptase
(TGIRT) could potentially allow higher read-through rates
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and thereby increase the signal. Another possibility could
be inclusion of Mn2+ in the reverse transcription buffer,
which in SHAPE-MaP-seq has been shown to increase RT
read-through rates of 2′ acetylated RNA positions (36).
While the study was under review, He et al. published the
m7G-seq method, which also use mutation mapping for de-
tection of m7G modifications. Compared to our method
m7G-seq includes an additional step to biotinylate the aba-
sic sites, which allows subsequent enrichment of the RNA
fragments. For this reason, m7G-seq will probably be bet-
ter to identify low frequency m7G modification than m7G-
MaP-seq. In future applications of m7G-MaP-seq, we plan
to combine our protocol with m7G specific antibody im-
munoprecipitation of RNA fragment (12,13,23) before the
NaBH4 treatment, which potentially would facilitate the de-
tection of positions with low frequency m7G modifications.
We demonstrate that m7G-MaP-seq detects known and
novel m7G modifications in rRNA and tRNA. In human
SSU rRNA, we detect the modification of position 1639,
which has previously been shown to be m7G modified by
WBSCR22-TRMT112 (4,5). Thismodification is conserved
to yeast SSU positionG1575 and here we show that the ara-
bidopsis SSU rRNA is alsomodified at the homologous po-
sition G1581 (Figure 2C), suggesting that SSUm7Gmethy-
lation is conserved between several eukaryotes and that ara-
bidopsis Bud23 homologRID2 is a functional m7Gmethyl-
transferase (37). In contrast, we did not observe any sig-
nal at position 1605, 2522 and 4550 in human LSU rRNA,
which were recently reported to be m7G modified based on
a high resolution cryoEM structure of the human 80S ri-
bosome (38). As in our study, the cryoEM study is based
on rRNA purified from HeLa cells, suggesting that the in-
consistent results are not cell type related. Our data, to-
gether with mass spectroscopy based analysis of human
LSU rRNA from the Isobe group (39), therefore strongly
suggests that m7G modifications are not reliably detected
from current cryoEMdata, which is furthermore supported
by the fact that the cryoEM study did not detect the well-
known m7G modification on SSU position 1639 (38).
We also applied m7G-MaP-seq to small RNA purified
from yeast, arabidopsis and human cells. In these experi-
ments, we observe m7G modifications on tRNAs only, for
which a subset is known to be m7G modified at position
46 in the variable loop, whereas no other sRNA was found
to be modified (Supplementary Figure S7). tRNA modifi-
cations have been most extensively annotated in yeast and
with m7G-MaP-seq we validate nine out of twelve tRNA
previously known to have m7G modifications in yeast. In
addition, we demonstrate m7G modifications on tRNA-
Pro-AGG and tRNA-Thr-TGT, which were not previously
known to be m7G modified. Our results are in agreement
with existing mapping of yeast m7G modifications, includ-
ing tRNAs previously found not to be m7G modiifed (Sup-
plementary Table S3) (11). By specifically analyzing the
reads containing tRNA introns, we find that for tRNAm7G
modifications occur early, before the tRNA intron has been
spliced out (Supplementary Figure S6), similar to what was
previously shown for m1A modifications (20). Among hu-
man tRNAs, we identify m7G modifications on 8 different
isodecoder families (Figure 4). Gregory and colleagues pre-
viously published the TRAC-seq method and applied it to
small RNA from mouse embryonic stem cells (12). Their
study implemented AlkB treatment to increase sequencing
depth of tRNA carrying modifications that terminate re-
verse transcription and convincingly identified the entire
subset of mouse tRNA that are m7G modified. Likewise,
He and colleagues applied their m7G-seq method to detect
m7G modifications human tRNA. Our results on human
tRNA agree with the TRAC-seq and m7G-seq data, but
we have sufficient sequencing depth on much fewer tRNAs.
Interestingly, our m7G-MaP-seq data shows that human
tRNA-Val-CAC-11 is not m7G modified, whereas tRNA-
Val-CAC-1, 2, 3 and 4 are all predicted to be m7G mod-
ified, although all these Val-CAC isodecoders have exactly
the same variable loop sequence. However, Val-CAC-11 has
a destabilized T-arm with one mismatch and three G-U
wobble basepairs, which may explain the lack of modifica-
tion as the T-arm was previously shown to be required for
m7G modification of yeast tRNA-Phe by purified Trm8–
Trm82 heterodimer (40). These results show the potential
of m7G-MaP-seq to distinguish tRNA isodecoders and de-
termine their m7G modification status. For arabidopsis tR-
NAs, we provide a preliminary annotation of m7G mod-
ifications, where 9 tRNAs were predicted to be modified.
Future implementation of AlkB treatment and/or TGIRT
in the m7G-MaP-seq protocol should facilitate a complete
annotation of m7G tRNAmodifications in arabidopsis and
for most other species for which no m7G modification an-
notation exists.
In a recent publication by Pandolfini et al., it was reported
that a subset of human miRNAs are m7Gmodified, includ-
ing Let-7e, for which the m7G modification was validated
and localized to position 18 using mass spectroscopy of a
RNaseA fragment of the gel purifiedmiRNA fraction (Fig-
ure 5A) (23). In HeLa cells, we demonstrate that Let-7e po-
sition is not m7Gmodified and we note that the sequence of
theLet-7eRNaseA fragment analysed by Pandolfini et al. is
identical to the human LSU rRNA 4336–4342 RNase A
fragment (Figure 5A). TheLSU rRNA4336–4342 fragment
has previously been analysed with mass spectroscopy and
was shown to be 2′ OMe modified on position 4340 (39),
which is in agreement with results from sequencing-based
2′ OMe mapping experiments on human ribosomal RNA
(41). LSU rRNA position 4340 and Let-7e position 18 are
both is position 5 in the RNase A fragments (Figure 5A),
meaning that the mass spectra obtained by Pandolfini and
colleagues for Let-7e m7G modification potentially could
be derived from rRNA contamination of the miRNA frac-
tion. Alternatively, the A549 cells used in their study may
have more abundant miRNA m7G modifications than the
HeLa cells used in our study.
Zhang et al. used mass spectroscopy on purified and de-
capped mRNA fractions from different human mouse cell
types and found that the mRNAs contained from 0.02 to
0.05% m7G when compared to the amount of G (13). They
also used m7G-seq to detect 803 human mRNA internal
m7G modifications that were detected in both HeLa and
HepG2 cells.We appliedm7G-MaP-seq tomRNAs purified
from E. coli and S. cerevisiae cells and did not identify any
m7G modified internal mRNA positions, whereas we in the
same experiment detect the known ribosomal m7G modifi-
cations with high significance (Figure 5). For both species,
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our analysis has high sequencing depth on a substantial
fraction ofGs in the transcriptome, 20 and 16 percent, forE.
coli and S. cerevisiae, respectively. We estimate that the cut-
off sequencing depth of 750 reads per group (1500 in total)
gives us around 90% power to detect a m7G modification
present at a frequency of 0.2, whereas a sequencing depth
of 3000 reads per group gives 90% power to detect a modi-
fication present at a frequency of 0.05 (Supplementary Fig-
ure S8). We therefore demonstrate that medium/high fre-
quency internal m7G modifications are not widespread in
E. coli andS. cerevisiaemRNA.Future application ofm7G-
seq or m7G-MaP-seq with higher sequencing depth and po-
tentially combined with antibody mediated m7G pull-down
will allow detection of potential low frequencym7Gmodifi-
cations in highly expressedmRNAand high frequencym7G
modifications in lowly expressed mRNA.
In conclusion, we have developed the m7G-MaP-seq
method, which allows high throughput detection of m7G
RNA modifications. The method can be implemented with
existing RNA-sequencing protocols and we provide an effi-
cient computational pipeline for data analysis. In this study,
we identify known and novel m7G modifications in rRNA
and tRNAand find that the humanLet-7e is notm7Gmodi-
fied inHeLa cells.We expect that them7G-MaP-seqmethod
will facilitate future studies on internal m7G RNA modifi-
cations.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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